OrbiMed Advisors »

Vistagen Therapeutics Ord shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 3.1M 3.55

More positions owned by OrbiMed Advisors

Boston Scientific Corporation (BSX)
Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)
Argenx Se Sponsored Adr (ARGX)
Sionna Therapeutics (SION)
Upstream Bio (UPB)
Disc Medicine (IRON)
Caris Life Sciences (CAI)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding Vistagen Therapeutics Ord

Henderson Group
OrbiMed Advisors
TCG Crossover Management
Stempoint Capital
Nantahala Capital Management
Vanguard Group
Commodore Capital
Ikarian Capital
Soleus Capital Management
Citadel Advisors
Diadema Partners
BlackRock
Renaissance Technologies
Susquehanna International
Jane Street

View all funds holding Vistagen Therapeutics Ord